Literature DB >> 21848967

Degenerative myelopathy in a Bernese Mountain Dog with a novel SOD1 missense mutation.

F A Wininger1, R Zeng, G S Johnson, M L Katz, G C Johnson, W W Bush, J M Jarboe, J R Coates.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21848967     DOI： 10.1111/j.1939-1676.2011.0760.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN： 0891-6640            Impact factor:   3.333


× No keyword cloud information.
  20 in total

1.  The chaperone protein clusterin may serve as a cerebrospinal fluid biomarker for chronic spinal cord disorders in the dog.

Authors:  Intan N F Shafie; Mark McLaughlin; Richard Burchmore; Mary Ann A Lim; Paul Montague; Pamela E J Johnston; Jacques Penderis; Thomas J Anderson
Journal:  Cell Stress Chaperones       Date:  2013-08-29       Impact factor: 3.667

Review 2.  From animal models to human disease: a genetic approach for personalized medicine in ALS.

Authors:  Vincent Picher-Martel; Paul N Valdmanis; Peter V Gould; Jean-Pierre Julien; Nicolas Dupré
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

3.  Human SOD1 ALS Mutations in a Drosophila Knock-In Model Cause Severe Phenotypes and Reveal Dosage-Sensitive Gain- and Loss-of-Function Components.

Authors:  Aslı Şahin; Aaron Held; Kirsten Bredvik; Paxton Major; Toni-Marie Achilli; Abigail G Kerson; Kristi Wharton; Geoff Stilwell; Robert Reenan
Journal:  Genetics       Date:  2016-12-14       Impact factor: 4.562

4.  Degenerative myelopathy in German Shepherd Dog: comparison of two molecular assays for the identification of the SOD1:c.118G>A mutation.

Authors:  Maria Teresa Capucchio; Veronica Spalenza; Elena Biasibetti; Maria Teresa Bottero; Roberto Rasero; Alessandra Dalmasso; Paola Sacchi
Journal:  Mol Biol Rep       Date:  2014-01-05       Impact factor: 2.316

5.  Molecular Epidemiological Survey for Degenerative Myelopathy in German Shepherd Dogs in Japan: Allele Frequency and Clinical Progression Rate.

Authors:  Shinichiro Maki; Md Shafiqul Islam; Tomohito Itoh; Masanobu Nurimoto; Akira Yabuki; Yu Furusawa; Hiroaki Kamishina; Yui Kobatake; Tofazzal Md Rakib; Martia Rani Tacharina; Osamu Yamato
Journal:  Animals (Basel)       Date:  2022-06-27       Impact factor: 3.231

6.  Characterization of intercostal muscle pathology in canine degenerative myelopathy: a disease model for amyotrophic lateral sclerosis.

Authors:  Brandie R Morgan; Joan R Coates; Gayle C Johnson; Alyssa C Bujnak; Martin L Katz
Journal:  J Neurosci Res       Date:  2013-09-16       Impact factor: 4.164

7.  Canine degenerative myelopathy: biochemical characterization of superoxide dismutase 1 in the first naturally occurring non-human amyotrophic lateral sclerosis model.

Authors:  Matthew J Crisp; Jeffrey Beckett; Joan R Coates; Timothy M Miller
Journal:  Exp Neurol       Date:  2013-05-23       Impact factor: 5.330

8.  Variants within the SP110 nuclear body protein modify risk of canine degenerative myelopathy.

Authors:  Emma L Ivansson; Kate Megquier; Sergey V Kozyrev; Eva Murén; Izabella Baranowska Körberg; Ross Swofford; Michele Koltookian; Noriko Tonomura; Rong Zeng; Ana L Kolicheski; Liz Hansen; Martin L Katz; Gayle C Johnson; Gary S Johnson; Joan R Coates; Kerstin Lindblad-Toh
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-16       Impact factor: 11.205

9.  A rare homozygous MFSD8 single-base-pair deletion and frameshift in the whole genome sequence of a Chinese Crested dog with neuronal ceroid lipofuscinosis.

Authors:  Juyuan Guo; Dennis P O'Brien; Tendai Mhlanga-Mutangadura; Natasha J Olby; Jeremy F Taylor; Robert D Schnabel; Martin L Katz; Gary S Johnson
Journal:  BMC Vet Res       Date:  2015-01-03       Impact factor: 2.741

10.  The prevalence of nine genetic disorders in a dog population from Belgium, the Netherlands and Germany.

Authors:  Bart J G Broeckx; Frank Coopman; Geert E C Verhoeven; Wim Van Haeringen; Leanne van de Goor; Tim Bosmans; Ingrid Gielen; Jimmy H Saunders; Sandra S A Soetaert; Henri Van Bree; Christophe Van Neste; Filip Van Nieuwerburgh; Bernadette Van Ryssen; Elien Verelst; Katleen Van Steendam; Dieter Deforce
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.